Moderna will complete the final test phase of the 30,000 trials this month, and hopes to market doses as early as spring • Pfizer may market as early as February • Meanwhile, pharmaceutical giant Astra-Zenica has encountered an unexpected hurdle • Also: Russia and China's big bet • Up-to-date picture
The race for the vaccine.
At best, vaccines will arrive in Israel in the spring, which will be given to the medical staff
Photography:
IP
The global fight against the corona plague has been going on vigorously since the beginning of 2020 while governments and research bodies have been working ever since to find a vaccine for the virus.
These days, a number of American companies and a British-Swedish company are on the finish line ahead of the announcement of an effective vaccine.
But when is each of the companies expected to announce it?
How long will it take to get the vaccines distributed?
And when will they come to our country?
"Israel Today" went out to check.
When will the vaccine arrive in Israel?
To this end, we spoke with Professor Amos Pent, from the Department of Biochemistry and Molecular Biology at the Hebrew University.
Pent, who works as a molecular virology expert, said: "There is currently a demand in the world of waiting and examining the depth of what has been achieved so far. 90 days, to confirm that he is good. "
Prof. Pant adds that "no matter which president sits in the White House, Republican or Democratic, it is clear that there will be tremendous pressure to approve the vaccine. "Therefore, I estimate that the first vaccine doses will arrive in Israel next April at the earliest and will be given first to the medical staffs.
Moderna's vaccine distribution is expected in the spring
When will a vaccine be announced?
The pharmaceutical and biotechnology company from the United States is based in the city of Cambridge, Massachusetts.
Today the company is at the peak of the latest test of the vaccine it has created based on the introduction of a genetic material, which is based on mRNA.
This substance causes the body's cells to produce parts of the virus, and it is these parts that trigger the required immune response.
The final phase will probably end in October after being tested on 30,000 people.
In fact, early results from this stage have shown great efficacy in adults.
How soon will the vaccines be distributed?
Despite the progress, the company is not yet ready to apply for a license to the US FDA and it looks like it will reach this stage at the end of November at best.
In light of this, the vaccine will start to be mass-produced this coming spring ie in 2021.
Mass production of Pfizer vaccine in February?
When will a vaccine be announced?
Another American company that is at the peak of the final stage in vaccine development is Pfizer.
The company is developing no less than four different vaccines against the virus together with the German pharmaceutical giant Biontech.
One of the vaccines is currently in the mass testing phase of 30,000 people.
The final results will be obtained at the end of the current month.
In fact, Pfizer is the Western company with the largest advantage in the field and the most experience in submitting applications to the FDA in the field of vaccines.
How soon will the vaccines be distributed?
Although the company could start out in November with a vaccine on the market, there seems to be a delay of at least another month.
This is due to a desire by medical professionals around the world to see the effects of the vaccine for two months after giving its last dose.
If all goes well, Pfizer may start producing vaccines in late January 2021 or early February.
In this way it will be the first Western society.
The barrier of Astra-Zenika
When will a vaccine be announced?
Another pharmaceutical company is the British-Swedish giant Astra-Zenika.
The company has embarked on a corona vaccine search in collaboration with Oxford University.
The company started in the last phase of its vaccine test, but here it encountered an obstacle.
One of the women who was vaccinated contracted spinal cord infection and therefore the US FDA is currently preventing the company from completing the third phase of the vaccine until the connection between the vaccine and the disease is clarified.
How soon will the vaccines be distributed?
However in Europe itself the company continues to carry out third and final stage vaccinations among volunteers.
But it seems that the company will lag behind in obtaining final approval for the vaccine and it will not reach the finish line before the end of the year or even the beginning of next year.
At best, the company will start mass production only in the spring.
Nova Vox Company
The American company involved in the development of vaccines has received approval to begin the third stage of testing for the corona virus.
The company is currently leading a major vaccination campaign in the United States and Europe.
A total of 30,000 people are expected to be vaccinated in two doses, in order to prove the effectiveness of the vaccine.
In fact, the company appears to be completing this phase towards mid-November and will begin a move with the FDA to obtain a license to manufacture its vaccine.
Johnson & Johnson
The American international giant has a vaccine against the Ebola virus that is considered similar to the corona virus.
The company therefore began a course of vaccine production for the corona virus.
These days Johnson & Johnson is giving the first dose of the vaccine to about 60,000 people worldwide.
The company is relatively late to the companies mentioned earlier and it seems that if everything works properly, it will receive approval for its vaccine between March and April 2021. Only then will it start distributing vaccine doses worldwide.
The exotic way of Russia and China
In addition to the Western companies mentioned here, there are two other countries that run companies that have actually started vaccinating already against the corona virus with vaccines developed in them.
The reference is to Russia and China.
Gamlia Institute:
This is the National Research Center for Epidemiology named after the Gamlia academic of the Ministry of Health in the Russian Federation.
The institute registered a patent in August for a vaccine against the corona that began to be mass-produced in the country and even the Russian army began vaccinating its fighters there.
This speed is due to the fact that the Russian research group has in fact skipped the world-accepted Phase 3 when it comes to medical immunization tests.
Instead, Russia began to simultaneously vaccinate the country’s population.
This is actually a gamble because there can be a number of scenarios.
In one case, it will be an effective vaccine that is accompanied by side effects.
Another option is an ineffective vaccine that is also accompanied by side effects.
Another scenario is of complete failure and possibly a health disaster in itself.
Whereas only in the fourth scenario is a vaccine possible and without significant side effects.
CanSino Biologics:
As mentioned, China also started vaccinating its citizens at the same time as testing the third and final phase.
This, by the Institute of Biotechnology of the Academy of Military Medical Sciences of China.
In fact the Chinese are repeating the Russian idea when here too all the scenarios mentioned above may occur.
